Premium
DKK3 attenuates the cytotoxic effect of natural killer cells on CD133 + gastric cancer cells
Author(s) -
Xia Pu,
Xu XiaoYan
Publication year - 2017
Publication title -
molecular carcinogenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.254
H-Index - 97
eISSN - 1098-2744
pISSN - 0899-1987
DOI - 10.1002/mc.22628
Subject(s) - biology , cytotoxic t cell , cancer stem cell , nkg2d , nk 92 , cancer research , cancer cell , cancer , lymphokine activated killer cell , cell culture , interleukin 21 , stem cell , immunology , microbiology and biotechnology , in vitro , biochemistry , genetics
Cancer stem cell (CSCs) has started a new era in cancer research. CD133 is a widely used marker for identification of CSCs. More and more studies showed that NK cells preferentially target cancer stem‐like cells. However, the deeper mechanism of the susceptibility of cancer stem cells to NK cells remains unclear. In this study, we isolated CD133 positive population of a gastric cancer cell line, BGC823 cells, and cultured with NK cells. We found that CD133 could efficiently active NK cells in an NKG2D‐dependent manner. DKK3 has been demonstrated as a suppressor in many cancers. Interestingly, we found that DKK3 suppressed CD133‐induced activation in NK cells by inhibiting Erk pathway and immunological synapse (IS) formation. NK cells‐based CSCs immunotherapy may be a novel approach for cancer therapy.